Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
Anika (NASDAQ: ANIK) will issue its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026.
Rhea-AI Summary
Anika (NASDAQ: ANIK) will issue its first quarter 2026 financial results before the market opens on Wednesday, April 29, 2026. A conference call to discuss results and business highlights will follow at 8:30 a.m. ET.
Investors can join by dialing 1-800-717-1738 (domestic) or 1-646-307-1865 (international) with conference ID 82141. A live audio webcast and presentation materials will be available and archived in the Investor Relations section of Anika's website at www.anika.com.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ANIK
On Apr 16, the first trading day after this news, ANIK closed 0.72% above the previous close.
Data tracked by StockTitan Argus for the Apr 16 session.
Key Figures
- Earnings release date
- April 29, 2026
- Planned Q1 2026 financial results announcement before market open
- Conference call time
- 8:30 a.m. ET
- Scheduled Q1 2026 earnings conference call
- Domestic dial-in
- 1-800-717-1738
- Toll-free U.S. number for Q1 2026 call
- International dial-in
- 1-646-307-1865
- International number for Q1 2026 call
- Conference ID
- 82141
- Access code for Q1 2026 earnings conference call
- Current share price
- $15.30
- Price before Q1 2026 earnings notice; near 52-week high
- 52-week high
- $15.475
- Ceiling over past 52 weeks; current price 1.13% below
- 52-week low
- $7.8701
- Floor over past 52 weeks; current price 94.41% above
Previous Earnings Reports
-
Reported Q4 and FY 2025 results with margin expansion and guidance.
-
Announced timing and call details for Q4 and year-end 2025 results.
-
Reported Q3 2025 revenue decline but highlighted key product and licensing advances.
-
Pre-announced Q3 2025 release date and earnings call logistics.
-
Detailed Q2 2025 revenue decline and missed trial endpoints with revised outlook.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BEDFORD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2026 financial results before the opening of the market on Wednesday, April 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) and providing the conference ID number 82141. A live audio webcast and accompanying presentation materials will be available in the Investor Relations section of Anika's website, www.anika.com. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Executive Director, Corporate Development and Investor Relations
investorrelations@anika.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.